Senior insider sale
ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$748.3K
30.66K shares
What this filing means
HERSHBERG ROBERT plans to sell 30.66K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $748.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2026ACC: 0001950047-26-008364
Director
Since Jun 2019
30.66K
Shares to sell
$748.3K
Approx. market value
30.66K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Stock Option Exercise
Cash
8/18/2026
15KRestricted Stock
Not Applicable
3/4/2025
15.66KTotal acquired30.66K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/18/2026 | Stock Option Exercise Cash | 15K | — |
3/4/2025 | Restricted Stock Not Applicable | 15.66K | — |
| Total | 30.66K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
30.66K
Market value
$748.3K
8/18/2026
Total
Units
30.66K
Value
$748.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/18/2026 | 30.66K | $748.3K | NASDAQ | Planned |
| Total | 30.66K | $748.3K | ||